Related Experiment Video
Updated: Jan 4, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.2K
Plasma exchange in catastrophic antiphospholipid syndrome
Ignasi Rodríguez-Pintó1, Miquel Lozano2, Joan Cid2
1Hospital Universitari Mutua de Terrassa, Systemic Autoimmune Disease Unit, Barcelona, Catalonia, Spain.
Presse Medicale (Paris, France : 1983)
|November 8, 2019
Summary
Plasma exchange effectively removes harmful substances in autoimmune disorders. In catastrophic antiphospholipid syndrome (CAPS), this therapy, alongside others, shows promise in improving patient outcomes despite limited clinical trials.
Area of Science:
- Immunology
- Hematology
- Nephrology
Background:
- Plasma exchange (PLEX) is a recognized treatment for autoimmune diseases, removing pathogenic factors like autoantibodies.
- Catastrophic Antiphospholipid Syndrome (CAPS) is a severe, life-threatening condition characterized by rapid, widespread thrombosis in patients with antiphospholipid antibodies.
- Current management of CAPS often involves a combination of anticoagulation, corticosteroids, and PLEX or intravenous immunoglobulins.
Purpose of the Study:
- To review the mechanisms of action and technical aspects of plasma exchange.
- To focus on the current role and published experience of PLEX in managing CAPS.
- To present an institutional treatment protocol for CAPS.
Main Methods:
- Review of existing literature on plasma exchange in autoimmune disorders and CAPS.
- Analysis of published case reports and series detailing PLEX use in CAPS.
- Description of a specific institutional protocol for plasma exchange in CAPS.
Main Results:
- Plasma exchange is presumed to benefit CAPS patients by eliminating autoantibodies, complement components, and cytokines.
- While formal trials are lacking due to CAPS rarity, observational data suggest improved clinical courses with PLEX-containing regimens.
- Physician experience guides the application of PLEX in CAPS, highlighting a need for standardized protocols.
Conclusions:
- Plasma exchange is an established, albeit experience-based, therapeutic option in catastrophic antiphospholipid syndrome.
- Further research and standardized protocols are needed to optimize the use of plasma exchange in CAPS.
- Understanding PLEX mechanisms and technicalities is crucial for its effective application in severe autoimmune conditions.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
260
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
260
01:29Venous Thrombosis III: Interprofessional Care
247
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
247
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
162
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
162
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
145
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
145
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
320
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
320